8 March 2021 - As part of our industry recruitment service, Feedinfo covers recent senior job moves within the global animal nutrition industry, helping industry colleagues keep up to date with new roles, board appointments and business changes. Please send any announcements to Recruitment@feedinfo.com
In addition, any organisations seeking to recruit specialist or senior staff can take advantage of Feedinfo’s recruitment service, which offers an audience of engaged and highly qualified animal nutrition specialists, managers, and executives. For more details, please contact our recruitment specialist, Dineo Komane at email@example.com
Recent moves (in alphabetical order of company) include:
Alltech Coppens named Ronald Faber as its CEO and global aquaculture lead. In this role, Faber will lead a global team of aquaculture experts who are experienced in fish nutrition, feed production and technical support.
Faber began his career in the aquaculture and veterinary industries and joined Coppens International in 1998 as an area sales manager for the Mediterranean region. In 2003, he moved to Thailand where he worked as a nutritional consultant for various fish and shrimp feed companies, serving customers in Thailand, Vietnam, India and Indonesia. He returned to the Netherlands in 2005 and continued his career with Coppens International, which was acquired by Alltech in 2016. Faber will be headquartered at the Alltech Coppens Aqua Centre (ACAC), an Alltech bioscience centre, where world-class research capabilities are applied to product development.
Boehringer Ingelheim announced the appointment of Randolph Legg as its U.S. President. He succeeds Everett Hoekstra, who retired in December.
Legg will remain head of the Company's U.S. commercial business while serving as president. Legg held various commercial leadership roles in Boehringer Ingelheim's Human Pharmaceutical division before moving to the company's Animal Health business in 2019 to lead the U.S. Pets Commercial team. He is based at the U.S. headquarters of Boehringer Ingelheim Animal Health in Duluth, Ga.
Devenish has expanded its business operations in Australia and New Zealand, with the appointment of Russell Trainor to the new role of Area Manager for Australasia.
Supported by the wider Devenish team including technical and product specialists, Russell will be responsible for driving business, sales growth and managing key accounts in Australia and New Zealand.
Elanco Animal Health announced the departure of executive vice president Michael-Bryant Hicks. He joined Elanco in 2018 as General Counsel and Corporate Secretary to prepare the company for IPO, build the Legal department structure for the stand-alone company, and complete the successful acquisition of Bayer Animal Health.
Merck CEO Ken Frazier will retire at the end of June.
Frazier, 66, will remain with the drug maker as executive chairman for a transition period to be determined by the board.
Frazier joined Merck nearly 30 years ago and climbed the ranks, attaining the CEO role of the Fortune 500 company in 2011. Under his leadership, cancer drug Keytruda raked in blockbuster sales and is now one of the leading products in a new generation of oncology treatments.